A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma

類似資料

• Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis
  著者:: Zhang, Xiao-Fei, 等
  出版事項: (2016)
• Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
  著者:: Jiang, Shan-Shan, 等
  出版事項: (2014)
• Overexpression of WWP1 Promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma
  著者:: Zhang, Xiao-Fei, 等
  出版事項: (2015)
• Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells
  著者:: Zhao, Jing-Jing, 等
  出版事項: (2014)
• PD-L1 expression patterns in tumour cells and their association with CD8(+) tumour infiltrating lymphocytes in clear cell renal cell carcinoma
  著者:: Zhu, Qian, 等
  出版事項: (2019)